These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 25780876)

  • 1. Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor.
    Preti D; Baraldi PG; Saponaro G; Romagnoli R; Aghazadeh Tabrizi M; Baraldi S; Cosconati S; Bruno A; Novellino E; Vincenzi F; Ravani A; Borea PA; Varani K
    J Med Chem; 2015 Apr; 58(7):3253-67. PubMed ID: 25780876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular docking screening using agonist-bound GPCR structures: probing the A2A adenosine receptor.
    Rodríguez D; Gao ZG; Moss SM; Jacobson KA; Carlsson J
    J Chem Inf Model; 2015 Mar; 55(3):550-63. PubMed ID: 25625646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bridging molecular docking to membrane molecular dynamics to investigate GPCR-ligand recognition: the human A₂A adenosine receptor as a key study.
    Sabbadin D; Ciancetta A; Moro S
    J Chem Inf Model; 2014 Jan; 54(1):169-83. PubMed ID: 24359090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of simplified N²-substituted pyrazolo[3,4-d]pyrimidine derivatives as novel adenosine receptor antagonists: efficient synthetic approaches, biological evaluations and molecular docking studies.
    Venkatesan G; Paira P; Cheong SL; Vamsikrishna K; Federico S; Klotz KN; Spalluto G; Pastorin G
    Bioorg Med Chem; 2014 Mar; 22(5):1751-65. PubMed ID: 24518296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation.
    Lebon G; Warne T; Edwards PC; Bennett K; Langmead CJ; Leslie AG; Tate CG
    Nature; 2011 May; 474(7352):521-5. PubMed ID: 21593763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel approaches for targeting the adenosine A2A receptor.
    Yuan G; Gedeon NG; Jankins TC; Jones GB
    Expert Opin Drug Discov; 2015 Jan; 10(1):63-80. PubMed ID: 25311639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of molecular modeling of agonist binding in light of the crystallographic structure of an agonist-bound A₂A adenosine receptor.
    Deflorian F; Kumar TS; Phan K; Gao ZG; Xu F; Wu H; Katritch V; Stevens RC; Jacobson KA
    J Med Chem; 2012 Jan; 55(1):538-52. PubMed ID: 22104008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The second extracellular loop of GPCRs determines subtype-selectivity and controls efficacy as evidenced by loop exchange study at A2 adenosine receptors.
    Seibt BF; Schiedel AC; Thimm D; Hinz S; Sherbiny FF; Müller CE
    Biochem Pharmacol; 2013 May; 85(9):1317-29. PubMed ID: 23500543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and structure-activity relationships of 2-hydrazinyladenosine derivatives as A(2A) adenosine receptor ligands.
    El-Tayeb A; Gollos S
    Bioorg Med Chem; 2013 Jan; 21(2):436-47. PubMed ID: 23245803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 7-Amino-2-aryl/hetero-aryl-5-oxo-5,8-dihydro[1,2,4]triazolo[1,5-a]pyridine-6-carbonitriles: Synthesis and adenosine receptor binding studies.
    Shaik K; Deb PK; Mailavaram RP; Chandrasekaran B; Kachler S; Klotz KN; Jaber AMY
    Chem Biol Drug Des; 2019 Aug; 94(2):1568-1573. PubMed ID: 30985956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine A
    Fuentes E; Fuentes M; Caballero J; Palomo I; Hinz S; El-Tayeb A; Müller CE
    Platelets; 2018 May; 29(3):292-300. PubMed ID: 28504052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic Role of the G Protein in Stabilizing the Active State of the Adenosine A
    Lee S; Nivedha AK; Tate CG; Vaidehi N
    Structure; 2019 Apr; 27(4):703-712.e3. PubMed ID: 30713025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, Synthesis, and Pharmacological Characterization of 2-(2-Furanyl)thiazolo[5,4-d]pyrimidine-5,7-diamine Derivatives: New Highly Potent A
    Varano F; Catarzi D; Vincenzi F; Betti M; Falsini M; Ravani A; Borea PA; Colotta V; Varani K
    J Med Chem; 2016 Dec; 59(23):10564-10576. PubMed ID: 27933962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A2A Adenosine Receptor Agonists and their Potential Therapeutic Applications. An Update.
    Guerrero A
    Curr Med Chem; 2018; 25(30):3597-3612. PubMed ID: 29532748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive profile of 2-thienyl-3,4-methylenedioxybenzoylhydrazone is mediated by activation of the A2A adenosine receptor.
    Leal CM; Pereira SL; Kümmerle AE; Leal DM; Tesch R; de Sant'Anna CM; Fraga CA; Barreiro EJ; Sudo RT; Zapata-Sudo G
    Eur J Med Chem; 2012 Sep; 55():49-57. PubMed ID: 22857782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine A2A receptor as a drug discovery target.
    de Lera Ruiz M; Lim YH; Zheng J
    J Med Chem; 2014 May; 57(9):3623-50. PubMed ID: 24164628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
    Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
    J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limonene, a natural cyclic terpene, is an agonistic ligand for adenosine A(2A) receptors.
    Park HM; Lee JH; Yaoyao J; Jun HJ; Lee SJ
    Biochem Biophys Res Commun; 2011 Jan; 404(1):345-8. PubMed ID: 21134357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of 7-(Prolinol-N-yl)-2-phenylamino-thiazolo[5,4-d]pyrimidines as Novel Non-Nucleoside Partial Agonists for the A2A Adenosine Receptor: Prediction from Molecular Modeling.
    Bharate SB; Singh B; Kachler S; Oliveira A; Kumar V; Bharate SS; Vishwakarma RA; Klotz KN; Gutiérrez de Terán H
    J Med Chem; 2016 Jun; 59(12):5922-8. PubMed ID: 27227326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and pharmacological evaluation of dual acting antioxidant A(2A) adenosine receptor agonists.
    Hausler NE; Devine SM; McRobb FM; Warfe L; Pouton CW; Haynes JM; Bottle SE; White PJ; Scammells PJ
    J Med Chem; 2012 Apr; 55(7):3521-34. PubMed ID: 22432713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.